Journal of Hematology

Editor-in-Chief
Farhad Ravandi, MD, Professor
Janiece and Stephen A. Lasher Professor of Medicine
Chief, Section of Acute Myeloid Leukemia
Department of Leukemia
The University of Texas MD Anderson Cancer Center, Texas, USA  Read more...

ISSN 1927-1212 print | ISSN 1927-1220 online | Bimonthly | Open Access | Aims and Scope

Indexed and covered by: Chemical Abstract (CA);
Worldcat; Google; Google Scholar; JournalTOCs; PubMed Central; PubMed; Web of Science, JCR Impact Factor 2023: 1.3

Journal archiving and digital preservation: Portico


Highlights

  • Efficacy of Frontline Chemotherapy for Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Network Meta-Analysis

    Treatment with non-anthracycline (ANT)-based chemotherapy has increased survival in patients with extranodal natural killer/T-cell lymphoma (ENKTCL). However, the relative efficacy of various drug combinations has been contentious.

    Read More >>
  • Harnessing the Immune System: An Effective Way to Manage Diffuse Large B-Cell Lymphoma

    Diffuse large B-cell lymphoma (DLBCL) is a heterogenous hematological disorder with malignant potential controlled by immunological characteristics of the tumor microenvironment. Rapid breakthrough in the molecular pathways has made immunological approaches the main anchor in the management of DLBCL, with or without chemotherapeutic agents.

    Read More >>
  • Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis

    Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy. ICI therapy is generally better tolerated than cytotoxic chemotherapy; however, hematological adverse events (AEs) have not been fully analyzed.

    Read More >>
  • Mature Type T-Lymphoblastic Leukemia/Lymphoma Presenting With Isolated Central Nervous System Symptomatology in a Patient With Giant Cell Arteritis on Long-Term Steroid Treatment

    T-lymphoblastic leukemia/lymphoma (T-ALL/T-LBL) is a malignancy comprised of T-lymphoblasts that can present as one of four clinical subtypes (pro-T, pre-T, cortical T, and mature T).

    Read More >>
  • Acute Myeloid Leukemia Following Myeloproliferative Neoplasms: A Review of What We Know, What We Do Not Know, and Emerging Treatment Strategies

    Acute myeloid leukemia (AML) arising from myeloproliferative neoplasms (MPNs) represents a small subtype of secondary AML (sAML). This entity is well known to be associated with poor responses to available treatment options and dismal outcomes.

    Read More >>

Featured

 

 

Featured

 

Real-World Data of Crizanlizumab in Sickle Cell Disease: A Single-Center Analysis
Crizanlizumab was approved by the United States Food and Drug Administration agency in 2019 for decreasing vaso-occlusive events (VOEs) in sickle cell disease (SCD). Data regarding the use of crizanlizumab in the real-world setting are limited. Full Text

Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia
Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, especially if treated with the first-generation Bruton’s tyrosine kinase inhibitor (BTKi) ibrutinib. Full Text


Key Clinical Image

Sickle Cell Trait: Is It Always Benign?
Sickle cell disease is a well-known homozygous inherited hemoglobinopathy that causes vaso-occlusive phenomena and chronic hemolysis. Vaso-occlusion results in sickle cell crisis and can eventually lead to complications involving multiple organ systems. However, the heterozygous counterpart, sickle cell trait (SCT) has less clinical significance as these patients are generally asymptomatic. Full Text


Current Issue

 

Vol. 13, No. 5, Oct 2024

Table of Contents

Original Article

Ferritin and Iron Levels Inversely Associated With Lymphoma Risk: A Mendelian Randomization Study Abstract HTML PDF
Boyuan Wu 179-185
doi: https://doi.org/10.14740/jh1335
Freedom From Bleeds With Low-Dose Emicizumab Prophylaxis in Inhibitor-Positive Hemophilia A Abstract HTML PDF
Nita Radhakrishnan, Archit Pandharipande, Savitri Singh, Shruti Verma, Eby P. Baby, Amit Pandey 186-191
doi: https://doi.org/10.14740/jh1346
The Influence of Circulating Exosomes Derived From Younger and Older Donors on Hypoxia-Inducible Factor 1 Alpha Gene Expression and P21 Protein in Cord Blood Hematopoietic Stem Cells Abstract HTML PDF
Zahra Rasti, Reza Afrisham, Elahe Bahrami Vahdat, Zahra Kashanikhatib, Seyed Hadi Mousavi, Shaban Alizadeh 192-199
doi: https://doi.org/10.14740/jh1291

Short Communication

Utility of p53 Immunohistochemical Staining for Risk Stratification of Mantle Cell Lymphoma Abstract HTML PDF
Ibrahim Elsharawi, Sorin Selegean, Michael Carter 200-206
doi: https://doi.org/10.14740/jh1333
Siltuximab in Idiopathic Multicentric Castleman Disease: Real-World Experience Abstract HTML PDF
Ciprian Jitaru, Argyris Symeonidis, Sorina Badelita, Eirini Katodritou, Andrei Colita, Anastasia Mpanti, Anamaria Bancos, Bogdan Tigu, Petra Rotariu, Laura Urian, Ioana Rus, Delia Dima, Anca Bojan, Marc Damian, Vasiliki Labropoulou, Mihai Stefan Muresan, Despina Fotiou, Bogdan Fetica, Bobe Petrushev, Angela Dascalescu, Dimitra Dalampira, Sanda Buruiana, Catalin Constantinescu, Mihnea Zdrenghea, Meletios A. Dimopoulos, Ciprian Tomuleasa, Evangelos Terpos 207-215
doi: https://doi.org/10.14740/jh1343

Case Report

Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma to Histiocytic/Dendritic Cell Sarcoma Abstract HTML PDF
Jennifer Cai, David Fernandez-Hazoury, Gene Yoshikawa, Amani Minja, Hehua Huang, Andrew Hwang, Xin Qing 216-223
doi: https://doi.org/10.14740/jh1310
Scedosporium Brain Abscess: A Rare and Fatal Drawback of Bruton Tyrosine Kinase Inhibitor Therapy Abstract HTML PDF
Matteo Dalmazzo, Melissa Padrini, Sofia Camerlo, Giorgio Rosati, Tiziano Tommaso Busana, Paolo Nicoli, Fabio Perotto, Luca Davicco, Pietro Caironi, Marco De Gobbi, Alessandro Morotti 224-228
doi: https://doi.org/10.14740/jh1263
Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood Associated With t(1;22)(p22;q11.2) Mutation Abstract HTML PDF
Lane Lerner, Sushanth Sreenivasan, Chelsea Peterson, Maitreyee Rai, Pragnan Kancharla, Samuel Santosa, Mark Bunker, Yazan Samhouri 229-237
doi: https://doi.org/10.14740/jh1284
Primary Refractory Discordant Diffuse Large B-Cell and Classical Hodgkin Lymphoma Abstract HTML PDF
Yuxin Bai, Samantha Bolger, Sahar Khan, Nikhil Sangle, Luojun Wang, Andrea L. Cervi 238-244
doi: https://doi.org/10.14740/jh1303
Successful Treatment of Idiopathic Multicentric Castleman Disease With Rash as the Initial Symptom Using a Rituximab-Based Regimen Abstract HTML PDF
Li Zhu, Yi Liu, Fang Yu, Xue Jiao Yin, Qiu Mei Yao, Hai Tao Meng, Liang Shun You, Hong Yan Tong 245-249
doi: https://doi.org/10.14740/jh1313
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis Abstract HTML PDF Suppl1
Charley Jang, Jingmei Hsu 250-258
doi: https://doi.org/10.14740/jh1327

Letter to the Editor

Controversies in the Management of Ischemic Cerebrovascular Accidents in Patients With Non-Promyelocytic Acute Myeloid Leukemia Abstract HTML PDF
Rodrick Babakhanlou, Ravinathan Krishnadasan 259-260
doi: https://doi.org/10.14740/jh1342
 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Hematology, bimonthly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.                            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org     elmer.editorial@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.